Journal Article


A randomised controlled trial of a digital intervention (renewed) to support symptom management, wellbeing and quality of life in cancer survivors

Abstract

Background: Many cancer survivors following primary treatment have prolonged poor quality of life. Aim: To determine the effectiveness of a bespoke digital intervention to support cancer survivors. Design: Pragmatic parallel open randomised trial. Setting: UK general practices. Methods: People having finished primary treatment (<= 10 years previously) for colo-rectal, breast or prostate cancers, with European-Organization-for-Research-and-Treatment-of-Cancer QLQ-C30 score <85, were randomised by online software to: 1)detailed ‘generic’ digital NHS support (‘LiveWell’;n=906), 2) a bespoke complex digital intervention (‘Renewed’;n=903) addressing symptom management, physical activity, diet, weight loss, distress, or 3) ‘Renewed-with-support’ (n=903): ‘Renewed’ with additional brief email and telephone support. Results: Mixed linear regression provided estimates of the differences between each intervention group and generic advice: at 6 months (primary time point: n’s respectively 806;749;705) all groups improved, with no significant between-group differences for EORTC QLQ-C30, but global health improved more in both intervention groups. By 12 months there were: small improvements in EORTC QLQ-C30 for Renewed-with-support (versus generic advice: 1.42, 95% CIs 0.33-2.51); both groups improved global health (12 months: renewed: 3.06, 1.39-4.74; renewed-with-support: 2.78, 1.08-4.48), dyspnoea, constipation, and enablement, and lower NHS costs (generic advice £265: in comparison respectively £141 (153-128) and £77 (90-65) lower); and for Renewed-with-support improvement in several other symptom subscales. No harms were identified. Conclusion: Cancer survivors quality of life improved with detailed generic online support. Robustly developed bespoke digital support provides limited additional short term benefit, but additional longer term improvement in global health enablement and symptom management, with substantially lower NHS costs.

Attached files

Authors

Little, Paul
Bradbury, Katherine
Stuart, Beth
Barnett, Jane
Krusche, Adele
Steele, Mary
Heber, Elena
Easton, Steph
Smith, Kirsten Ailsa
Slodkowska-Barabasz, Joanna
Payne, Liz
Corbett, Teresa
Yao Guiqing
Pollet, Sebastien
Smith, Jazzine
Joseph, Judith
Lawrence, Megan
Bohning, Dankmar
Cheetham-Blake, Tara
Eccles, Diana
Foster, Claire
Geraghty, Adam W.A.
Leydon, Geraldine
Muller, Andre
Neal, Richard
Osborne, Richard
Rathod, Shanaya
Richardson, Alison
Grimmett, Chloe
Sharman, Geoff
Bacon, Roger
Turner, Lesley
Stephens, Richard
Burford, Tamsin
Wilde, Laura
Middleton, Karen
Liddiard, Megan
Rogers, Kirsty
Raftery, James
Zhu Shihua
Webley, Fran
Griffiths, Gareth
Nutall, Jaqui
Chalder, Trudie
Wilkinson, Clare E.
Watson, Eila
Yardley, Lucy

Oxford Brookes departments

Department of Nursing

Dates

Year of publication: 2023
Date of RADAR deposit: 2024-01-31


Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License


Related resources

This RADAR resource is Identical to A randomised controlled trial of a digital intervention (renewed) to support symptom management, wellbeing and quality of life in cancer survivors

Details

  • Owner: Joseph Ripp
  • Collection: Outputs
  • Version: 1 (show all)
  • Status: Live
  • Views (since Sept 2022): 538